MétaCan
Menu
Back to cohort
Record W4381984096 · doi:10.1016/j.imu.2023.101267

Minimization of drug interactions in polypharmacy treatments of diabetes mellitus type 2 with cardiovascular comorbidities by using the decision support tool PM-TOM

2023· article· en· W4381984096 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

aboutThe title or abstract carries a Canadian signal from the geographic lexicon.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueInformatics in Medicine Unlocked · 2023
Typearticle
Languageen
FieldComputer Science
TopicComputational Drug Discovery Methods
Canadian institutionsnot available
Fundersnot available
KeywordsPolypharmacyMedicineDiabetes mellitusType 2 Diabetes MellitusPharmacologyDrugAngiotensin Receptor BlockersType 2 diabetesInternal medicinePharmacotherapyAngiotensin-converting enzymeEndocrinology

Abstract

fetched live from OpenAlex

Combined polypharmacy treatments of multi-diseases like diabetes mellitus type 2 (DMT2) with its comorbidities could lead to serious adverse reactions (ADR) due to drug-drug interactions (DDIs). This study aimed to demonstrate that these DDI ADRs can be significantly reduced by carefully examining DDIs of recommended drugs and using advanced clinical decision support (CDS) tools, like PM-TOM (Personal Medicine: Therapy Optimization Method). DMT2 with heart failure (HF) and atherosclerotic cardiovascular disease (ASCVD) were taken for analysis. First, 20 drug classes were selected, recommended in relevant medical guidelines (US, European and Canadian); for example, biguanides, sodium-glucose transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, insulins, angiotensin 2 receptor blockers, angiotensin-converting enzyme inhibitors, beta-adrenergic blockers, diuretics, and statins. Next, these classes were combined into polypharmacy treatment cases, which were organized into three groups: Basic (combinations of three drug classes), Medial (five), and Advanced (eight). Then, the tool PM-TOM was used to find treatments with minimal and maximal drug interactions (MIN-DDI and MAX-DDI) for each case. Finally, these two treatments' minimal, average and maximal DDIs were calculated and statistically analyzed to examine the scope and effects of optimizing polypharmacy treatments in each case group. In the Basic group, 16 polypharmacy treatment cases were created; in the Medial 210 and the Advanced 736. The MIN-DDI and MAX-DDI treatments in each case group showed significant DDI differences; for example, in the Basic group, the average DDI count in the MIN-DDI treatments was 0.19 and in the MAX-DDI ones 1.75, while in the Medial and Advanced groups, these indicators were 1.66 and 7.66, and 5.76 and 20.52, respectively. Also, 87% of optimized treatments (MIN-DDI) in the Basic group showed no DDIs, 37% in the Medial, and 9% in the Advanced. In addition, 70% of cases in the Medial group had at most two DDIs, and 49% in the Advanced group at most five. These findings suggest that DDI ADRs in randomly selected (unoptimized) DMT2 polypharmacy treatments can be substantially reduced using specialized decision support tools, increasing patients' chances for successful treatment and decreasing health care costs. Similar findings can be expected for other multi-diseases as well.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.158
Threshold uncertainty score0.348

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.002
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.038
GPT teacher head0.342
Teacher spread0.304 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it